Literature DB >> 12739747

Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?

F Bogazzi1, E Martino, L Bartalena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12739747     DOI： 10.1007/BF03345148

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  18 in total

Review 1.  Is thyroxine during lithium therapy necessary?

Authors:  L Bartalena; F Bogazzi; E Martino
Journal:  J Endocrinol Invest       Date:  1999-03       Impact factor: 4.256

Review 2.  Radioiodine therapy for Graves' disease: case selection and restrictions recommended to patients in North America.

Authors:  L Wartofsky
Journal:  Thyroid       Date:  1997-04       Impact factor: 6.568

3.  The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.

Authors:  H B Burch; B L Solomon; D S Cooper; P Ferguson; N Walpert; R Howard
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

4.  Current trends in the management of Graves' disease.

Authors:  B Solomon; D Glinoer; R Lagasse; L Wartofsky
Journal:  J Clin Endocrinol Metab       Date:  1990-06       Impact factor: 5.958

Review 5.  Is thyroxine during lithium therapy necessary?

Authors:  J H Lazarus
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

6.  Pretreatment with propylthiouracil but not methimazole reduces the therapeutic efficacy of iodine-131 in hyperthyroidism.

Authors:  R E Imseis; L Vanmiddlesworth; J D Massie; A J Bush; N R Vanmiddlesworth
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

7.  Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication.

Authors:  O Sabri; M Zimny; G Schulz; M Schreckenberger; P Reinartz; K Willmes; U Buell
Journal:  J Clin Endocrinol Metab       Date:  1999-04       Impact factor: 5.958

Review 8.  Management of Graves' ophthalmopathy: reality and perspectives.

Authors:  L Bartalena; A Pinchera; C Marcocci
Journal:  Endocr Rev       Date:  2000-04       Impact factor: 19.871

9.  The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.

Authors:  V A Andrade; J L Gross; A L Maia
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

10.  Comparison of radioiodine with radioiodine plus lithium in the treatment of Graves' hyperthyroidism.

Authors:  F Bogazzi; L Bartalena; S Brogioni; G Scarcello; A Burelli; A Campomori; L Manetti; G Rossi; A Pinchera; E Martino
Journal:  J Clin Endocrinol Metab       Date:  1999-02       Impact factor: 5.958
View more
  1 in total

1.  Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.

Authors:  Sarah Côté-Bigras; Viet Tran; Sylvie Turcotte; Marek Rola-Pleszczynski; Jean Verreault; Diane Rottembourg
Journal:  Endocrine       Date:  2015-12-23       Impact factor: 3.633
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.